CU-BX Overview
- Year Founded
-
2013
- Status
-
Out of Business
- Employees
-
6
- Latest Deal Type
-
Out of Business
CU-BX General Information
Description
Developer of a health monitoring technology designed to deliver personalized actionable insights that improve quality of life. The company's patented artificial intelligence system offers a clinically validated, contact-free technology that can remotely detect signs of pulmonary congestion in the home, supporting the timely detection of changes in lung fluid content, enabling patients with congestive heart failure and other chronic cardiopulmonary diseases by monitoring their health daily, freeing them to focus on living their life to the fullest and helping to prevent avoidable rehospitalization.
Contact Information
Website
www.cubxauto.comCorporate Office
- HaNechoshet Street 6
- Tel Aviv 6971070
- Israel
Corporate Office
- HaNechoshet Street 6
- Tel Aviv 6971070
- Israel
CU-BX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Out of Business | 01-Feb-2025 | Completed | Out of Business | |||
| 12. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 11. Later Stage VC | 01-Oct-2022 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series 1) | 14-Dec-2021 | Completed | Generating Revenue | |||
| 9. Grant | 08-Dec-2021 | Completed | Generating Revenue | |||
| 8. Grant | 19-Jan-2021 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 12-Jun-2018 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 08-Mar-2018 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2018 | $7.9M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 01-Dec-2017 | $7.9M | Completed | Generating Revenue |
CU-BX Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B3 | ||||||||
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series A3 | ||||||||
| Series A2 | 6,000,000 | $0.000100 | $0.56 | $0.56 | 1x | $0.56 | 13.64% | |
| Series A1 | 6,000,000 | $0.000100 | $0.3 | $0.3 | 1x | $0.3 | 12.63% |
CU-BX Comparisons
Industry
Financing
Details
CU-BX Competitors (11)
One of CU-BX’s 11 competitors is Rijuven, a Formerly VC-backed company based in Wexford, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Rijuven | Formerly VC-backed | Wexford, PA | ||||
| GOQii | Venture Capital-Backed | Menlo Park, CA | ||||
| Noom | Venture Capital-Backed | Princeton, NJ | ||||
| Endomag | Formerly VC-backed | Cambridge, United Kingdom | ||||
| MediPines | Venture Capital-Backed | Yorba Linda, CA |
CU-BX Patents
CU-BX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210172883-A1 | System and method for passively monitoring a sample | Inactive | 05-Dec-2019 | ||
| JP-2020151474-A | System and method for optical monitoring using symmetry condition of light field | Pending | 19-Mar-2019 | ||
| US-10861171-B2 | System and method for optical monitoring using symmetry condition of light field | Inactive | 19-Mar-2019 | ||
| US-20200302620-A1 | System and method for optical monitoring using symmetry condition of light field | Active | 19-Mar-2019 | ||
| US-20200232915-A1 | Speckle based sensing of acoustic excitation in solutions | Inactive | 22-Jan-2019 | G01N29/2418 |
CU-BX Signals
CU-BX FAQs
-
When was CU-BX founded?
CU-BX was founded in 2013.
-
Where is CU-BX headquartered?
CU-BX is headquartered in Tel Aviv, Israel.
-
What is the size of CU-BX?
CU-BX has 6 total employees.
-
What industry is CU-BX in?
CU-BX’s primary industry is Therapeutic Devices.
-
Is CU-BX a private or public company?
CU-BX is a Private company.
-
What is CU-BX’s current revenue?
The current revenue for CU-BX is .
-
How much funding has CU-BX raised over time?
CU-BX has raised $27.4M.
-
Who are CU-BX’s competitors?
Rijuven, GOQii, Noom, Endomag, and MediPines are some of the 11 competitors of CU-BX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process